Sat, Oct 25, 2014, 6:19 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Arrowhead Research Corp. Message Board

  • chem2mc1 chem2mc1 Aug 7, 2014 7:01 PM Flag


    FDA partially released hold status of TKM-siRNA KD Ebola and TKMR pps fly.. I said just few days ago TKMR is good stock and should buy it. ( with good LNP delivery ,however, LNP seems have more safety issue than DPC ( many sci article review this ) ...
    Ebola based on animal rule for approve, FDA and everybody knows, however, chimps result is very reliable and very closely correlation with human clinical . TKMR good news should PUMP ARWR since they are all the same siRNA tech based and all against the virus ( with decoy ability smart virus ) .

    Please do your research. Animal rules solely based animal trial data to get FDA approval that is based on Sci that Chimps data just very reliably " duplicate " human clinical data...
    Think about if ARWR PhIIa data just duplicate their own chimp data and ALNY chimp data with ALT flare....

    If that is case, I truly believe ARWR pps action would Dwarf TKMR since HBV is huge market but Ebola is just none

    SortNewest  |  Oldest  |  Most Replied Expand all replies
7.16+0.24(+3.47%)Oct 24 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.